APT Pharmaceuticals is focused on the development of cyclosporine inhalation solution (CIS) for the prevention and treatment of chronic rejection in lung transplantation. The company has successfully enrolled a large, multi-center Phase III clinical trial evaluating the effect of CIS on chronic rejection and is preparing for commercialization of the product in the US and Europe.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 700 Airport Blvd., Ste. 350, Burlingame,ca 94010,united States
- Phone
- 650-931-1666
- in****@****bio.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- aptbio.com
- HQ
- Burlingame, CA
Apt Pharmaceuticals Questions
Apt Pharmaceuticals's helpline number is 650-931-1666
Apt Pharmaceuticals's website is aptbio.com
Apt Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/apt-pharmaceuticals
Apt Pharmaceuticals has
7 employees.
View email and phone details for 7
employees at Apt Pharmaceuticals.
Apt Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Apt Pharmaceuticals's top competitors are
Bright Future Pharmaceutical Lab. Ltd.,
Raaha Llc,
Zhejiang Shenzhou Pharmaceutical Co., Ltd,
Sgs,
Sublime Law, Pllc,
Terns Pharmaceuticals,
Government Laboratory,
Novo Nordisk,
Thomas R. Brown Foundations,
Emsd.
Apt Pharmaceuticals's support email address is info@aptbio.com
Apt Pharmaceuticals's categories are Pharmaceutical Manufacturing
Apt Pharmaceuticals's founding year is 2005
